{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:17:04Z","timestamp":1789690624025,"version":"4.0.1"},"reference-count":34,"publisher":"Tech Science Press","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OR"],"published-print":{"date-parts":[[2025]]},"DOI":"10.32604\/or.2024.056282","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T01:46:16Z","timestamp":1730771176000},"page":"723-731","source":"Crossref","is-referenced-by-count":3,"title":["Exploring the utility of a NGS multigene panel to predict BCG response in patients with non-muscle invasive bladder cancer"],"prefix":"10.32604","volume":"33","author":[{"given":"PAOLA","family":"GAZZANIGA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BELARDINILLI","family":"FRANCESCA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MICHELA DE","family":"MEO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CHIARA","family":"NICOLAZZO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GIUSEPPE","family":"GIANNINI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FRANCESCO DEL","family":"GIUDICE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CARLO MARIA","family":"SCORNAJENGHI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ETTORE DE","family":"BERARDINIS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LUCA","family":"MARINO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FABIO MASSIMO","family":"MAGLIOCCA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"VALENTINA","family":"MAGRI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BENJAMIN","family":"INBEH CHUNG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JAN","family":"\u0141ASZKIEWICZ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"17807","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","volume":"81","author":"Babjuk","year":"2022","journal-title":"Eur Urol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"110393","DOI":"10.1016\/j.biopha.2020.110393","article-title":"Mechanisms of BCG in the treatment of bladder cancer-current understanding and the prospect","volume":"129","author":"Han","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"329","DOI":"10.6004\/jnccn.2020.0011","article-title":"Bladder cancer, version 3.2020, NCCN clinical practice guidelines in oncology","volume":"18","author":"Flaig","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41585-018-0055-4","article-title":"Mechanisms of BCG immunotherapy and its outlook for bladder cancer","volume":"15","author":"Pettenati","year":"2018","journal-title":"Nat Rev Urol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.trivac.2014.08.002","article-title":"Non-specific immunity of BCG vaccine: a perspective of BCG immunotherapy","volume":"3","author":"Iqbal","year":"2014","journal-title":"Trials Vaccinol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/S0140-6736(98)07422-4","article-title":"BCG immunotherapy of bladder cancer: 20 years on","volume":"353","author":"Alexandroff","year":"1999","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/ITT.S202006","article-title":"Bacillus calmette-Gu\u00e9rin (BCG) therapy for bladder cancer: an update","volume":"9","author":"Guallar-Garrido","year":"2020","journal-title":"Immunotargets Ther"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/184291a0","article-title":"Effect of bacillus calmette-guerin infection on transplanted tumours in the mouse","volume":"184","author":"Old","year":"1959","journal-title":"Nature"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"615091","DOI":"10.3389\/fimmu.2020.615091","article-title":"Immunological hallmarks for clinical response to BCG in bladder cancer","volume":"11","author":"Lim","year":"2021","journal-title":"Front Immunol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/sj.bjc.6602026","article-title":"Role of urothelial cells in BCG immunotherapy for superficial bladder cancer","volume":"91","author":"Bevers","year":"2004","journal-title":"Br J Cancer"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1158\/0008-5472.CAN-12-1882","article-title":"Oncogenic activation of Pak1-dependent pathway of macropinocytosis determines BCG entry into bladder cancer cells","volume":"73","author":"Redelman-Sidi","year":"2013","journal-title":"Cancer Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.trecan.2019.04.002","article-title":"Macropinocytosis in cancer: a complex signaling network","volume":"5","author":"Zhang","year":"2019","journal-title":"Trends Cancer"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41568-020-00313-1","article-title":"Advances in bladder cancer biology and therapy","volume":"21","author":"Tran","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3390\/cells12030493","article-title":"Targeted sequencing approach and its clinical applications for the molecular diagnosis of human diseases","volume":"12","author":"Pei","year":"2023","journal-title":"Cells"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.annonc.2020.07.014","article-title":"Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO precision medicine working group","volume":"31","author":"Mosele","year":"2020","journal-title":"Ann Oncol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"560","DOI":"10.3389\/fonc.2020.00560","article-title":"Clinical multigene panel sequencing identifies distinct mutational association patterns in metastatic colorectal cancer","volume":"10","author":"Belardinilli","year":"2020","journal-title":"Front Oncol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3390\/cancers11020147","article-title":"A simplified genomic profiling approach predicts outcome in metastatic colorectal cancer","volume":"11","author":"Capalbo","year":"2019","journal-title":"Cancers"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3390\/cancers14030802","volume":"14","author":"Nicolazzo","year":"2022","journal-title":"Cancers"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"20180157","DOI":"10.1098\/rstb.2018.0157","article-title":"Macropinosomes as units of signal transduction","volume":"374","author":"Swanson","year":"2019","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"ref20","first-page":"4529","article-title":"Research progress on the PI3K\/AKT signaling pathway in gynecological cancer","volume":"19","author":"Shi","year":"2019","journal-title":"Mol Med Rep"},{"key":"ref21","first-page":"4296","article-title":"Two distinct functions for PI3-kinases in macropinocytosis","volume":"126","author":"Hoeller","year":"2013","journal-title":"J Cell Sci"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cell.2017.09.007","article-title":"Comprehensive molecular characterization of muscle-invasive bladder cancer","volume":"171","author":"Robertson","year":"2017","journal-title":"Cell"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13073-022-01056-4","article-title":"Combined exome and transcriptome sequencing of non-muscle-invasive bladder cancer: associations between genomic changes, expression subtypes, and clinical outcomes","volume":"14","author":"Goel","year":"2022","journal-title":"Genome Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.purol.2018.03.008","article-title":"Interest of next-generation sequencing in BCG-treated high-risk bladder cancer","volume":"28","author":"Jungels","year":"2018","journal-title":"Prog Urol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"4658","DOI":"10.1158\/0008-5472.CAN-17-3199","article-title":"The canonical Wnt pathway drives macropinocytosis in cancer","volume":"78","author":"Redelman-Sidi","year":"2018","journal-title":"Cancer Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"4599","DOI":"10.1158\/1078-0432.CCR-21-0205","article-title":"Identification of a novel inflamed tumor microenvironment signature as a predictive biomarker of bacillus Calmette-Gu\u00e9rin immunotherapy in non-muscle-invasive bladder cancer","volume":"27","author":"Damrauer","year":"2021","journal-title":"Clin Cancer Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.eururo.2022.09.008","article-title":"Elevated T-cell exhaustion and urinary tumor DNA levels are associated with bacillus Calmette-Gu\u00e9rin failure in patients with non-muscle-invasive bladder cancer","volume":"82","author":"Strandgaard","year":"2022","journal-title":"Eur Urol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.devcel.2009.06.016","article-title":"Wnt\/\u03b2-catenin signaling: components, mechanisms, and diseases","volume":"17","author":"MacDonald","year":"2009","journal-title":"Dev Cell"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"e8261","DOI":"10.7717\/peerj.8261","article-title":"Significance of TP53 mutation in bladder cancer disease progression and drug selection","volume":"7","author":"Wu","year":"2019","journal-title":"PeerJ"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"947","DOI":"10.3390\/ijms21030947","article-title":"TERT promoter mutation as a potential predictive biomarker in BCG-treated bladder cancer patients","volume":"21","author":"Batista","year":"2020","journal-title":"Int J Mol Sci"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.euo.2021.11.002","article-title":"Somatic features of response and relapse in non-muscle-invasive bladder cancer treated with bacillus Calmette-Gu\u00e9rin immunotherapy","volume":"5","author":"Bacon","year":"2022","journal-title":"Eur Urol Oncol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.eururo.2017.05.032","article-title":"Next-generation sequencing of nonmuscle invasive bladder cancer reveals potential biomarkers and rational therapeutic targets","volume":"72","author":"Pietzak","year":"2017","journal-title":"Eur Urol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.eururo.2009.04.038","article-title":"An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Gu\u00e9rin for non-muscle-invasive bladder cancer","volume":"56","author":"Malmstr\u00f6m","year":"2009","journal-title":"Eur Urol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.eururo.2011.05.045","article-title":"Long-term cancer-specific survival in patients with high-risk, non-muscle-invasive bladder cancer and tumour progression: a systematic review","volume":"60","author":"van den Bosch","year":"2011","journal-title":"Eur Urol"}],"container-title":["Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cdn.techscience.cn\/files\/or\/2025\/TSP_OR-33-3\/OncolRes-33-03-56282\/OncolRes-33-56282.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T06:22:05Z","timestamp":1763101325000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.techscience.com\/or\/v33n3\/59644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":34,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025]]},"published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.32604\/or.2024.056282","relation":{},"ISSN":["1555-3906"],"issn-type":[{"value":"1555-3906","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}